Literature DB >> 29794677

ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.

.   

Abstract

Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Its etiology remains unknown, and treatment is largely symptom based and empirical. PCOS has the potential to cause substantial metabolic sequelae, including an increased risk of diabetes and cardiovascular disease, and these factors should be considered when determining long-term treatment. The purpose of this document is to examine the best available evidence for the diagnosis and clinical management of PCOS.

Entities:  

Mesh:

Year:  2018        PMID: 29794677     DOI: 10.1097/AOG.0000000000002656

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  28 in total

Review 1.  Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women.

Authors:  Anna C O'Kelly; Erin D Michos; Chrisandra L Shufelt; Jane V Vermunt; Margo B Minissian; Odayme Quesada; Graeme N Smith; Janet W Rich-Edwards; Vesna D Garovic; Samar R El Khoudary; Michael C Honigberg
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

2.  A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification.

Authors:  Olatokunbo Osibogun; Oluseye Ogunmoroti; Olamide B Kolade; Allison G Hays; Victor Okunrintemi; Anum S Minhas; Martha Gulati; Erin D Michos
Journal:  J Womens Health (Larchmt)       Date:  2022-05-16       Impact factor: 3.017

Review 3.  Acupuncture for Female Infertility: Discussion on Action Mechanism and Application.

Authors:  Jing-Yu Xu; An-Lan Zhao; Ping Xin; Jun-Ze Geng; Bao-Juan Wang; Tian Xia
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-04       Impact factor: 2.650

4.  Efficacy of Bariatric Surgery in the Treatment of Women With Obesity and Polycystic Ovary Syndrome.

Authors:  Lili Hu; Li Ma; Xinyi Xia; Tao Ying; Minzhi Zhou; Shuhua Zou; Haoyong Yu; Jun Yin
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

5.  The Association of Polycystic Ovary Syndrome and Gestational Hypertensive Disorders in a Diverse Community-Based Cohort.

Authors:  Diane Schneider; Joel R Gonzalez; Miya Yamamoto; Jingrong Yang; Joan C Lo
Journal:  J Pregnancy       Date:  2019-01-01

6.  Evaluation and management of amenorrhea related to congenital sex hormonal disorders.

Authors:  Ju Young Yoon; Chong Kun Cheon
Journal:  Ann Pediatr Endocrinol Metab       Date:  2019-09-30

7.  Measures of Patient Dissatisfaction With Health Care in Polycystic Ovary Syndrome: Retrospective Analysis.

Authors:  Luis R Hoyos; Manesha Putra; Abigail A Armstrong; Connie Y Cheng; Carrie K Riestenberg; Tery A Schooler; Daniel A Dumesic
Journal:  J Med Internet Res       Date:  2020-04-21       Impact factor: 5.428

8.  Nationwide survey on the usage of ovulation-induction agents among obstetricians and gynecologists in China.

Authors:  Yan Deng; Yan-Fang Wang; Shi-Yang Zhu; Wei Xue; Xiao Ma; Rui-Lin Ma; Ai-Jun Sun
Journal:  Chin Med J (Engl)       Date:  2019-10-20       Impact factor: 2.628

9.  The therapeutic effects of glucagon-like peptide-1 receptor agonists and metformin on polycystic ovary syndrome: A protocol for systematic review and meta-analysis.

Authors:  Ruilin Ma; Xuesong Ding; Yanfang Wang; Yan Deng; Aijun Sun
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

10.  MiR-23a induced the activation of CDC42/PAK1 pathway and cell cycle arrest in human cov434 cells by targeting FGD4.

Authors:  Ji Lin; Huijuan Huang; Liheng Lin; Weiwei Li; Jianfen Huang
Journal:  J Ovarian Res       Date:  2020-08-09       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.